The Critical Role of Pathologists and Molecular Technologies in Clinical Trial Success

  • Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
  • Overview of pathology and the expertise of pathologists in tissue evaluation and procurement for clinical trial success
  • Best practices for tissue and liquid biopsy selection, handling, and quality assurance, including considerations for ctDNA and MRD testing.
  • Case-based examples demonstrating optimal specimens for clinical trial enrollment, as well as common pitfalls in tissue and ctDNA/MRD workflows leading to case failures.
  • How Natera harnesses real-world data from its commercial pipeline to accelerate clinical trial advancement and enrollment

The real reason trials fail isn’t recruitment… it’s design

  • Why most oncology trial delays are designed in before the first patient is enrolled
  • How Pharma, Biotech and CRO teams are using AI to eliminate amendments before they happen
  • What it takes to build a protocol that actually works operationally, globally, and regulator-ready from day one

PRIZE DRAW

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon giftcards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

Interactive Speaker-Hosted Roundtable Discussions

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within oncology clinical trials. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Roundtable 1 Balancing quality, speed and cost in complex oncology trials

Umar Hayat Ph.D., Founder, CEO, Accanito Therapeutics Inc

Roundtable 2 Is AI overhyped? Understanding how to incorporate AI to enhance trial processes

Radha Duttagupta, Vice President, Clinical Affairs, Nucleix

Roundtable 3 Leveraging strong academic networks for complex oncology trials to assist in research and drug development

Irene Acerbi Soto, Clinical Implementations & Operations Manager, University of California San Francisco

Roundtable 4 Tissue is the Issue: How to overcome limited oncologic samples to achieve clinical trial success

Osama Khan MD, FCAP, FRCPC, Anatomical Pathologist, Oncology, Natera